HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Distribution Drives C&D’s TheraBreath Growth Plan

Executive Summary

In addition to advertising brand to consumers and expanding distribution,, C&D will promote TheraBreath dental hygienists along with to Waterpik power brushes and water-flossers.

You may also be interested in...



Church & Dwight Delivers 5% Net Growth Despite Slumps For Major Brands, International Sales

Sales in most categories in US portfolio grew, led by Zicam, Therabreath and Hero. But slumps continued for Waterpik water flossers, the Flawless feminine hair-removal, skin and nail care line and the vitafusion and L’il Critter gummies and other vitamin, mineral and supplement products.

Church & Dwight ‘Left Money On Table’ In Q1, Same Supply Chain Problems Expected Q2 Before Easing

“We have the orders, we’re just struggling to fill them either due to production problems or transportation issues,” says CEO Matthew Farrell.

US Q1 Consumer Health Earnings Preview: Pivoting From Planning Changes To Parsing Results

Inflation's impact on consumer spending will be front and center in sector’s quarterly reports, beginning with J&J on 19 April. Potential impact also from price hikes common from most firms since early 2021 in response to increasing costs. Russia’s invasion of Ukraine also will prompt comment.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152160

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel